Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Matthay

Showing results (1-10 of 316) with videos related to

Pageof 32
Sort By:
Advances in Pediatrics|January 1, 1985
Monoclonal antibodies in the diagnosis and treatment of childhood diseasesK K Matthay
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 17, 1998
Stage 4S neuroblastoma: what makes it special?K K Matthay
Journal of Nuclear Biology and Medicine (Turin, Italy : 1991)|October 1, 1991
An overview on the treatment of neuroblastomaK K Matthay
Oncology (Williston Park, N.Y.)|January 22, 1998
Neuroblastoma: biology and therapyK K Matthay
Pediatric Transplantation|December 10, 1999
Intensification of therapy using hematopoietic stem-cell support for high-risk neuroblastomaK K Matthay
The Lancet. Oncology|November 17, 2018
Interleukin 2 plus anti-GD2 immunotherapy: helpful or harmful?Katherine K Matthay
CA: a Cancer Journal for Clinicians|May 1, 1995
Neuroblastoma: a clinical challenge and biologic puzzleK K Matthay
The Lancet. Oncology|March 1, 2008
Chemotherapy for neuroblastoma: does it hit the target?Katherine K Matthay
Bone Marrow Transplantation|December 1, 1996
Impact of myeloablative therapy with bone marrow transplantation in advanced neuroblastomaK K Matthay
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 31, 2000
MYCN expression in neuroblastoma: A mixed message?K K Matthay
Pageof 32

Showing results (1-10 of 316) with videos related to

Sort By:
Pageof 32
Advances in Pediatrics|January 1, 1985
Monoclonal antibodies in the diagnosis and treatment of childhood diseasesK K Matthay
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 17, 1998
Stage 4S neuroblastoma: what makes it special?K K Matthay
Journal of Nuclear Biology and Medicine (Turin, Italy : 1991)|October 1, 1991
An overview on the treatment of neuroblastomaK K Matthay
Oncology (Williston Park, N.Y.)|January 22, 1998
Neuroblastoma: biology and therapyK K Matthay
Pediatric Transplantation|December 10, 1999
Intensification of therapy using hematopoietic stem-cell support for high-risk neuroblastomaK K Matthay
The Lancet. Oncology|November 17, 2018
Interleukin 2 plus anti-GD2 immunotherapy: helpful or harmful?Katherine K Matthay
CA: a Cancer Journal for Clinicians|May 1, 1995
Neuroblastoma: a clinical challenge and biologic puzzleK K Matthay
The Lancet. Oncology|March 1, 2008
Chemotherapy for neuroblastoma: does it hit the target?Katherine K Matthay
Bone Marrow Transplantation|December 1, 1996
Impact of myeloablative therapy with bone marrow transplantation in advanced neuroblastomaK K Matthay
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 31, 2000
MYCN expression in neuroblastoma: A mixed message?K K Matthay
Pageof 32